Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01419210 · ClinicalTrials.gov registry record · NA

Pilot Program to Personalize Care & Improve Quality of Life for Women With Ovarian Cancer

A NA study, sponsored by H. Lee Moffitt Cancer Center and Research Institute.

Completed
Registry status
NA
Development phase
28
Enrollment target

NCT01419210 is a NA study that has completed, run by H. Lee Moffitt Cancer Center and Research Institute. The registered enrollment target is 28 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01419210, a NA study, has completed, sponsored by H. Lee Moffitt Cancer Center and Research Institute.

COMPLETED
Registry status
NA
Development phase
28 participants
Enrollment target

Study Summary

The purpose of this study is to find out if complementary and alternative medicines (CAM) should be included with traditional therapy for women with ovarian cancer. Some of the alternative medicines include non-traditional drug and herbal therapies along with dietary and nutritional strategies. Only a few of these alternative medicines have been tested with women with ovarian cancer.

Interventions

  • OTHER Pre-study Questionnaire
  • OTHER Educational Presentations
  • OTHER CAM Therapies
  • OTHER Post-study Questionnaire

Trial Details

FieldValue
Enrollment Target 28 participants
Start Date 2010-01
Est. Completion 2015-09
Phase NA

What the Registry Record Tells You About NCT01419210

The ClinicalTrials.gov registry entry for NCT01419210 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is H. Lee Moffitt Cancer Center and Research Institute, which has 502 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 4 interventions - of which Pre-study Questionnaire is the first listed.

NCT01419210 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01419210 about?

NCT01419210 is a clinical study titled "Pilot Program to Personalize Care & Improve Quality of Life for Women With Ovarian Cancer". The purpose of this study is to find out if complementary and alternative medicines (CAM) should be included with traditional therapy for women with ovarian cancer. Some of the alternative medicines include non-traditional drug and herbal therapies along with dietary and nutritional strategies. Only...

What is the current status of trial NCT01419210?

This trial is currently completed. It is a NA study. The enrollment target is 28 participants. The study started on 2010-01. Estimated completion is 2015-09.

What interventions are being tested in trial NCT01419210?

The interventions under investigation include: Pre-study Questionnaire (OTHER), Educational Presentations (OTHER), CAM Therapies (OTHER), Post-study Questionnaire (OTHER).

Who is sponsoring clinical trial NCT01419210?

This trial is sponsored by H. Lee Moffitt Cancer Center and Research Institute, which has 502 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.